Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ZYMEWORKS-INC-34658200/news/Zymeworks-Inc-New-Clinical-Data-for-Zanidatamab-in-HER2-HR-Metastatic-Breast-Cancer-Presented-T-42528570/?utm_source=whatsapp&utm_medium=social&utm_campaign=share